Candida auris, a multi-drug-resistant fungal pathogen, has become an emerging threat in healthcare settings around the world. Reliable disinfection protocols specifically designed to inactivate C. auris are essential, as many chemical disinfectants commonly used in healthcare settings have been shown to have variable efficacy at inactivating C. auris.
Background: Candida auris, a multi-drug-resistant fungal pathogen, has become an emerging threat in healthcare settings around the world. Reliable disinfection protocols specifically designed to inactivate C. auris are essential, as many chemical disinfectants commonly used in healthcare settings have been shown to have variable efficacy at inactivating C. auris.
Conclusion: UVGI is a feasible approach for inactivating C. auris, although variable susceptibility among isolates must be taken into account. This dose–response data is critical for recommending UVGI dosing strategies to be tested in healthcare settings.
